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ABSTRACT
Objective: To measure brain volume
deficits among underweight patients
with anorexia nervosa (AN) compared to
control participants and evaluate the re-
versibility of these deficits with short-
term weight restoration.
Method: Brain volume changes in gray
matter (GM), white matter (WM), and cer-
ebrospinal fluid (CSF) were examined in
32 adult women with AN and compared
to 21, age and body mass index-range
matched control women.
Results: Patients with AN had a signifi-
cant increase in GM (p 5 .006, g2 5 0.14)
and WM volume (p 5 .001, g2 5 0.19) fol-
lowing weight restoration. Patients on av-
erage had lower levels of GM at low weight
(647.63 6 62.07 ml) compared to controls
(679.93 6 53.31 ml), which increased with
weight restoration (662.64 6 69.71 ml),
but did not fully normalize.
Discussion: This study suggests that
underweight adult patients with AN have
reduced GM and WM volumes that
increase with short-term weight restora-
tion. VC 2010 by Wiley Periodicals, Inc.
Keywords: anorexia nervosa; magnetic
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Introduction
Anorexia nervosa (AN) is a serious psychiatric ill-
ness characterized by relentless dieting and weight
loss. The starvation promoted by the illness affects
multiple physiological systems in the human body
causing metabolic, endocrine, and cardiovascular
abnormalities.1 Brain volume deficits and
increased cerebrospinal fluid (CSF) observed in
underweight individuals with AN suggest that the
brain is not spared the deleterious effects of starva-
tion.2–7 More specifically, one small study (N 5 13)
found that underweight adolescents with AN had
greater ventricular, sulcal, and total CSF volumes
and less gray matter (GM) and white matter (WM)
volumes compared to healthy control participants.8
These findings, with the exception of WM deficits,
were replicated in another small sample (N 5 12)
of underweight children and adolescents with AN.9
When this patient sample was evaluated 7 months
after weight restoration, there were increases in
GM volume and decreases in CSF over time. Simi-
larly, two studies examining changes in adult
patients with AN observed decreases in CSF and
increases in brain matter immediately following
weight restoration,5,10 and others have observed a
reversal of ventricular enlargement with weight res-
toration.3,6,7 However, it remains unclear whether
brain volume fully normalizes with acute weight
restoration.9–11
Because many of the existing studies have only
examined adolescents with the restricting subtype
of AN, the first aim of this study was to examine
changes in brain volume accompanied by weight
restoration among adult inpatients meeting full cri-
teria for either the restricting or binge/purge sub-
types of AN. We hypothesized that patients with AN
would experience increases in GM and WM with
short-term weight gain. The second aim was to
examine how GM and WM volumes in patients
with AN at low-weight and normal weight com-
pared to the brain volumes of healthy control par-
ticipants. We hypothesized that underweight
patients would have deficits in GM and WM when
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compared with controls and that these deficits




Participants were adult women with AN engaged in
inpatient treatment on the Eating Disorders service of
the General Clinical Research Unit of the New York State
Psychiatric Institute at Columbia University Medical
Center. Forty patients were recruited to participate in two
longitudinal functional magnetic resonance imaging
(fMRI) studies examining responses to food. As part of
those fMRI studies, standard T1-weighted structural
scans were obtained, allowing for brain volume assess-
ments. To be eligible for the study, patients had to (1)
meet DSM-IV criteria for AN (except for amenorrhea); (2)
have no other Axis I disorder other than major depres-
sion; (3) be women between the ages of 18 and 45; (4) be
free of psychotropic medication; (5) not be pregnant or
lactating; (6) not have any nonremovable metal on their
body, or other contraindications for MRI (e.g. claustro-
phobia); (7) be medically stable; and (8) have no history
of suicide attempt or other self-injurious behavior within
the previous 6 months.
Twenty-six healthy women control participants were
also recruited via flyers to participate. Eligibility criteria for
controls included (1) women between the ages of 18 and
45; (2) no current or past psychiatric illness; (3) no history
of binge eating or vomiting; (4) body mass index (BMI)
between 18 and 23 kg/m2; (5) not currently taking medica-
tion; (6) no significant medical or neurologic illness; (7)
not pregnant or lactating; and (8) no nonremovable metal
on their body, or other contraindications for MRI.
The Structured Clinical Interview for DSM-IV was used
to diagnose patients and screen controls.12 Height was
measured by stadiometer to the nearest [1/4] in., and
weight was measured on a beam balance scale by a
research assistant and used to calculate BMI. A psychia-
trist (LESM) met with all patients and controls to deter-
mine whether they met the additional eligibility criteria.
Patients also provided self-report data on duration of
illness.
Participants were initially scanned within the first
2 weeks of hospitalization after they were deemed medi-
cally stable and before the beginning of the weight-gain
phase of treatment. Patients were rescanned after reach-
ing 90% of ideal body weight (IBW) based on the 1959
Metropolitan Life Insurance Tables.13 Two of the partici-
pating patients requested to be discharged from the hos-
pital before reaching 90% of IBW, but had gained a signif-
icant amount of weight placing them at a BMI above
18.0 kg/m2, and were rescanned before discharge.
Controls were also scanned twice. The New York State
Psychiatric Institute/Columbia University Department of
Psychiatry Institutional Review Board for the protection
of human participants approved this study, and informed
consent was obtained for all participants.
MRI Acquisition
High-resolution spoiled gradient-recalled echo T1-
weighted axial images (TE/TR 5/19 ms, flip angle 208,
22 3 17-cm field of view, 256 3 256 3 114 matrix, yield-
ing an in-plane resolution of 0.859 3 0.859 mm and slice
thickness 1.5 mm) were acquired on a 1.5T General Elec-
tric Twin Speed MRI machine.
Image Analysis
An optimized voxel-based morphometry procedure
was used as described in Ashburner and Friston14 and
Good et al.15 using SPM5 (Wellcome Department of Cog-
nitive Neurology, London, UK) to derive tissue volumes.
Those conducting the segmentation were blind to partic-
ipant diagnostic status. Individual images were spatially
normalized into standardized stereotactic space and seg-
mented into three tissue types using prior probabilities
provided by SPM5. Default settings were used for this
procedure. During the spatial normalization step, images
were corrected by the Jacobian determinant to maintain
volumetric information,15 and each voxel intensity value
reflected its true volume. Total volumes were determined
by summing across voxel intensity values for each tissue
type (i.e., GM, WM, and CSF).
Statistical Analysis
Data analysis was performed using SPSS 15.0 (Chicago,
IL). First, two sets of independent samples two-tailed
t-tests were conducted to assess potential differences
between patients and controls and patients with either
binge-purge or restricting subtype of AN on age, height,
BMI, and time between scans. For our primary analyses,
we performed three two-factor repeated measures
ANOVAs to assess changes in GM, WM, and CSF over
time and possible interactions between brain volume
and participant status (patient vs. control). All ANOVAs
included total intracranial volume (derived by summing
GM, WM, and CSF) as a covariate. Eta-squared effect
sizes are reported for these analyses, and interpretation
is based on Cohen’s guidelines (small 5 0.01, medium 5
0.06, and large 5 0.14).16 Significant omnibus tests were
followed with tests of simple effects to examine differen-
ces in brain volume between patients at low weight com-
pared to controls as well as patients at normal weight
compared to controls. Cohen’s d was calculated as a mea-
sure of effect size for these comparisons, and interpreta-
tion was based on Cohen’s guidelines (small 5 0.2, me-
dium 5 0.5, and large 5 0.8).16 Finally, Pearson correla-
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tions were performed to determine if the GM, WM, or
CSF volumes of patients at low weight were associated
with BMI and/or duration of illness and if changes in
GM, WM, or CSF volumes were correlated with changes
in BMI. We used a p-value of less than 0.05 to denote sta-
tistical significance for all analyses.
Results
Three patients’ and one control’s follow-up scans
could not be reliably segmented into three tissue
types (i.e., GM, WM, and CSF) and were therefore
excluded from the analyses. Five patients and four
controls failed to complete a second scan and so were
excluded from the analyses. Thus, data from 32
patients and 21 controls were assessed. Fourteen
patients (43.75%) had AN-restricting subtype, and 18
patients (56.25%) had AN-binge/purge subtype. These
two subtype groups did not significantly differ on age,
height, duration of illness, or BMI at scan 2 (data not
shown). The subtype groups did significantly differ on
scan 1 BMI (p 5 .01), with the restricting subtype
group having a lower BMI (M 15.24 kg/m2 SD 1.51 vs.
M 16.65 kg/m2 SD 1.40 for the binge/purge subtype
group). Both groups were combined into one sample
for all of the analyses. The patient group did not differ
significantly from the control group on age, height, or
BMI after patients had normalized their weight,
although the patient group was significantly under-
weight at the initial scan compared to controls. The
difference in age, scan dates, and the second scan
BMI violated the equality of variances assumption
based on the Levene test, and so t-tests, degrees of
freedom, and significance levels for these variables
reflect values based on the Welch–Satterthwaite
approach. Demographic and clinical information is
presented in Table 1.
There was a significant interaction between scan
time and participant status (patient vs. control) on
GM [F(1,50) 5 8.28, p 5 .006, g2 5 0.14], indicating
that GM changes differed by participant status. The
tests of simple effects were significant when compar-
ing GM volumes between patients and controls at
scan 1 (when patients were underweight) (p\ 0.001,
d 5 0.56) and at scan 2 (when patients were weight-
restored) (p 5 .039, d 5 0.30). Patients on average
had lower GM volumes at scan 1 compared to con-
trols, which increased over time, but remained signif-
icantly lower than controls after weight restoration
(see Fig. 1).
There was a significant interaction between scan
time and participant status [F(1,50) 5 12.01, p 5
.001, g2 5 0.19], with the patient group experienc-
ing an increase in WM over time that was not pres-
ent in the control group. Tests of simple effects did
not reveal significant differences in WM volume
between patients and controls at the first scan (p 5
.229, d 5 0.17) or the second scan (p 5 .947, d 5
2.03) (see Fig. 2). There was not a significant inter-
action between scan time and participant status for
CSF volumes [F(1,50) 5 1.30, p 5 .259, g2 5 0.03].
See Table 2 for results.
When patients were underweight, BMI was not sig-
nificantly correlated with GM, WM, or CSF volumes.
However, duration of illness was correlated with GM
volume at low weight (q 5 2.472, p 5 .007), but not
with WM or CSF volumes. The change in BMI
between the low weight and weight-restored scans
was significantly correlated with the change in GM (q
5 .549, p 5 .001) and the change in WM (q 5 .405, p
5 .022), but not with the change in CSF. Duration of
illness was not correlated with any of the brain volume
changes.





(n 5 21) Ind Samples t-Test
Mean SD Mean SD t df p
Age (years) 26.91 6.41 25.00 3.18 21.44 48.12 0.158
Height (in.) 63.61 2.52 64.35 2.30 1.076 51 0.287
Scan 1 BMI
(kg/m2)a
16.03 1.59 20.82 1.22 10.27 35 0.000
Scan 2 BMI
(kg/m2)
20.01 0.59 20.60 1.17 2.10 25.13 0.050
Time between
scans (days)




a Significant difference between patients and controls, p\ 0.05.
FIGURE 1. The graph shows mean gray matter volume
for patients with anorexia nervosa and controls at scan one
and scan two. Error bars represent standard deviations.
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Discussion
This study confirmed our first hypothesis that adult
patients with AN would experience an increase in
GM and WM volumes following short-term weight
restoration. Our second hypothesis that patients
would have GM and WM deficits compared to con-
trols at low-weight, which would resolve after
weight-restoration was also partially confirmed.
Significant deficits in GM were observed at low
weight. These deficits improved with short-term
weight restoration, but did not fully normalize. A
significant increase in WM volume was also
observed, but post hoc tests of simple effects did
not reveal significant differences in WM between
patients and controls at either scan. However, given
that WM increased over time, it appears that WM
deficits may have been present when patients were
underweight. There was also no significant differ-
ence between patients and controls in WM vol-
umes at the second scan. Although this suggests
that WM volume may fully normalize with short-
term weight gain, the results should be interpreted
with caution given the small sample size. Consider-
ing all of these findings together, we draw the fol-
lowing conclusions: (1) GM deficits were present at
low weight and GM volume increased with weight
gain, but did not fully normalize; (2) WM volume
increased with weight gain, suggesting that WM
deficits were present at low weight and may nor-
malize with weight restoration.
We were able to replicate Katzman et al.’s8 obser-
vation that adolescent underweight patients with
the restricting subtype of AN had deficits in GM
when patients were underweight in a larger sample
of adult patients with both binge/purge and restrict-
ing subtypes of AN compared to controls. However,
unlike Katzman et al., we did not detect significant
differences in WM when patients were underweight,
though our findings suggest that these deficits may
exist in our sample as well. The larger sample size of
this study improved upon Swayze and colleagues5
study, which examined an adult sample of patients
with AN (though only eight patients met diagnostic
criteria for full syndrome AN, and the sample
included a male with BN and a male with EDNOS).
They failed to find significant differences in GM and
WM and attributed this to their small sample size. In
a second study of 13 adult patients, Swayze et al.10
observed increased CSF volume at low weight, but
again did not see deficits in total GM. They did how-
ever observe deficits in total WM, and while we did
not observe this, the increase in WM over time in
our sample suggests that WM deficits at low weight
were likely present. In addition, we replicated their
finding that GM and WM significantly increase fol-
lowing weight restoration.
It will be important for future research to further
explore differences in brain volume deficits
between adolescent and adult populations and
between the different AN subtypes. Castro-
Fornieles and colleagues9 argued that GM is more
affected than WM in adolescents, which appears to
be true in our sample as well, although we also
observed increases in WM. We also detected an
inverse correlation between duration of illness and
lower volumes of GM at low weight, but no correla-
tion between low weight BMI and brain volume
measures. This suggests that greater brain volume
deficits are experienced the longer a patient has
AN. This is in contrast to Katzman et al.,8 who
observed a correlation between BMI and brain vol-
ume, but not duration of illness. This disparity may
represent differences in adolescent populations
who have not been ill for very long versus adult
populations where duration of illness and thus du-
ration at lower weight may prove to be a more im-
portant indicator of brain volume loss than current
BMI. However, Swayze et al.10 also saw a significant
correlation between initial BMI and all global brain
and CSF volumetric measurements and, as we
FIGURE 2. The graph shows mean white matter volume
for patients with anorexia nervosa and controls at scan one
and scan two. Error bars represent standard deviations.
TABLE 2. Brain volume comparisons between patients
and controls
Patients (N5 32) Controls (N5 21)
First Scan Second Scan First Scan Second Scan
Mean SD Mean SD Mean SD Mean SD
GM (ml)a 647.63 62.07 662.64 69.71 679.93 53.31 680.91 52.35
WM (ml)a 479.22 51.42 489.99 51.04 488.22 53.68 488.36 55.54
CSF (ml) 276.57 47.61 267.70 49.20 229.05 45.24 229.02 40.82
a Significant interaction between patient/control group and scan time,
p\ 0.05.
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observed, also detected a significant relationship
between changes in volume and changes in BMI.
The correlation between BMI and volume changes
suggests that starvation plays a central role in brain
deficits among patients with AN, although the
mechanism through which starvation impacts
brain volume remains unclear.
Katzman and colleagues have hypothesized that
one mechanism may be cortisol levels.8 They note
that underweight patients with AN have elevated
levels of cortisol comparable to those seen in Cush-
ing disease, which is also often accompanied by
brain atrophy. Katzman and colleagues have
observed a correlation between high levels of corti-
sol and GM deficits, but because we did not obtain
measures of cortisol, we could not assess this rela-
tionship in this study. Future research should exam-
ine deficits in specific structures particularly vulner-
able to excess cortisol, such as the hippocampus.
Although this study evaluated a larger sample size
than most other existing studies, it remains limited
by a small number of participants. However, there
are a number of additional strengths. The study
used a longitudinal design that included individuals
who met full criteria for both binge/purge and
restricting subtypes of AN. The design was also
strengthened by the inclusion of age and BMI
range-matched controls who were also scanned
twice at the same time intervals as patients.
Future research should use longitudinal designs
to aim to replicate these findings in a larger adult
sample as well as explore potential differences in
subtypes of AN. In addition, it will be important to
clarify if and when brain volume normalizes with
longer term weight maintenance. Lambe et al.17
examined brain volume after long-term mainte-
nance (between 1 and 23 years) in 12 individuals
with a past history of AN-restricting subtype and
found that compared to controls, weight-recovered
patients had smaller total GM volumes and greater
total CSF volumes. No differences in total WM vol-
umes emerged between the groups, but based on
our findings, this WM reversal may have occurred
early in the recovery process. Similarly, Katzman
et al.18 found that among six adolescent patients
with AN who were rescanned 2–3 years after main-
taining normal weight, there were no differences in
WM when compared with controls, but GM deficits
and elevated CSF volumes remained. However,
Wagner et al.19 performed a cross-sectional study
comparing 30 adult women with AN who had been
recovered for 1 year and did not find any differen-
ces in total GM, WM, and CSF between patients
and controls. Overall, these findings are mixed, and
conclusions based on small sample sizes need to
be interpreted with caution, because the failure to
detect differences does not mean real differences
do not exist. Finally, although a study of adoles-
cents did not find an association between cognitive
deficits and brain volume deficits,20 the impact of
these structural changes on brain function (e.g.
cognitive abilities) among adult patients with AN
requires additional research. McCormick et al.21
found that reductions in right dorsal anterior cin-
gulate cortex volume in underweight patients with
AN were related to difficulties with perceptual or-
ganization and conceptual reasoning. Furthermore,
the smaller changes in right dorsal anterior cingu-
late cortex volume were associated with poorer
response to treatment. These findings suggest that
future research should focus on regional analyses
in addition to overall brain volume.
The authors thank the patients and staff of the General
Clinical Research Unit at the New York State Psychiatric
Institute as well as the anonymous manuscript reviewers
for their valuable feedback.
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